Loading clinical trials...
Loading clinical trials...
To Evaluate the Efficacy and Safety of Xinnaoning Capsule in Treating Chronic Stable Angina Pectoris (Qi Stagnation and Blood Stasis Syndrome) : a Randomized, Double-blind, Parallel Controlled, Multi-center Clinical Study
Conditions
Interventions
Xinnaoning Capsule
Xinnaoning Capsule Simulator
Locations
1
China
Xiyuan Hospital, Chinese Academy of Traditional Chinese Medicine
Beijing, Beijing Municipality, China
Start Date
May 15, 2018
Primary Completion Date
December 1, 2019
Completion Date
April 1, 2020
Last Updated
April 16, 2019
Lead Sponsor
Beijing Duheng for Drug Evaluation and Research Co., Ltd. (DDER)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions